NCT04158986

Brief Summary

In a randomized controlled trial, the effects of a nurse-driven post-discharge intervention for patients with liver cirrhosis compared with standard follow-up will be investigated.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
110

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 23, 2019

Completed
20 days until next milestone

First Posted

Study publicly available on registry

November 12, 2019

Completed
19 days until next milestone

Study Start

First participant enrolled

December 1, 2019

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 13, 2021

Completed
12 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2022

Completed
Last Updated

December 30, 2022

Status Verified

December 1, 2022

Enrollment Period

1.9 years

First QC Date

October 23, 2019

Last Update Submit

December 29, 2022

Conditions

Outcome Measures

Primary Outcomes (3)

  • Time from discharge to first readmission.

    Time from discharge to first readmission.

    Time from discharge to first readmission during all readmissions due to liver cirrhosis in the 6 month trial time.

  • Number of readmissions

    Number of readmissions within 2 years

    Number of readmissions within 2 years.

  • Duration of readmissions

    Duration of readmissions due to liver cirrhosis

    Duration of readmissions due to liver cirrhosis in the 6 month trial time.

Secondary Outcomes (4)

  • Health related quality of life before and after intervention

    The change in health related quality of life before and after intervention (6 months trial time).

  • Self-perceived health before and after intervention

    The change in self-perceived health before and after intervention (6 months trial time).

  • Functional disability in work-, social-, and family life before and after intervention

    The change in functional disability in work-, social-, and family life before and after intervention (6 months trial time)

  • Mortality

    The mortality rate after 6 months, 12 months and 2 years

Study Arms (2)

Standard treatment

NO INTERVENTION

Receives standard post-discharge care with planned follow-up in the clinic for liver failure or ambulatory.

Nurse-driven post-discharge intervention

EXPERIMENTAL

Participates in a nurse-driven post-discharge intervention program.

Behavioral: Nurse-driven post-discharge intervention

Interventions

Home visits based on the concepts of Family Nursing: The participants will receive three home visits by a nurse who is trained in the Family Nursing principles during the first 12 weeks after discharge. The home visits will comprise of: * Filling in the Chronic Liver Disease Questionnaire. * Therapeutic conversations including drawing and review of genogram and eco-map. * Information about- and help to initiate contact to relevant municipal offers. * Evidence-based information based on the patient's current problems or symptoms, base-line knowledge and receptiveness. Follow-up telephone calls: • After the first 12 weeks participants will be followed-up by telephone monthly during the following 12 weeks. Pamphlet: • All participants will receive a pamphlet with brief information regarding preventive measures and early signs of decompensation as well as relevant contact details. The pamphlet will be handed out before discharge

Nurse-driven post-discharge intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients diagnosed with liver cirrhosis and one or more complications hereto during admission to the Gastro Unit, AHH. Complications include, but are not limited to: hepatic encephalopathy, infection, ascites, edema, kidney failure, upper or lower GI bleeding.
  • Patients must read and understand Danish.
  • Adults \>18 years.

You may not qualify if:

  • When the diagnosis of liver cirrhosis is questioned with reasonable doubt or the diagnosis of liver cirrhosis is disproved by histology or relevant imaging.
  • Patients with comorbidity as the primary diagnosis and where an independent rehabilitation or post-discharge program is offered, for example hip fracture, chronic obstructive pulmonary disease etc.
  • Patients diagnosed with an active and invasive malignant disease.
  • Residency outside the catchment area of Amager Hvidovre Hospital.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Copenhagen University Hospital, Amager Hvidovre

Copenhagen, Hvidovre, 2650, Denmark

Location

Related Publications (1)

  • Barfod O'Connell M, Brodsgaard A, Matthe M, Hobolth L, Wullum L, Bendtsen F, Kimer N. A randomized controlled trial of a postdischarge nursing intervention for patients with decompensated cirrhosis. Hepatol Commun. 2024 Apr 26;8(5):e0418. doi: 10.1097/HC9.0000000000000418. eCollection 2024 May 1.

MeSH Terms

Conditions

Liver Cirrhosis

Condition Hierarchy (Ancestors)

Liver DiseasesDigestive System DiseasesFibrosisPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Malene Barfod O'Connell, RN, MScPH

    Amager Hvidovre Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Allocation is blinded.
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
RN, PhD student

Study Record Dates

First Submitted

October 23, 2019

First Posted

November 12, 2019

Study Start

December 1, 2019

Primary Completion

October 13, 2021

Study Completion

October 1, 2022

Last Updated

December 30, 2022

Record last verified: 2022-12

Locations